Trial Profile
A Phase II Study of R115777 (Zarnestra) in Superficial Transitional Cell Carcinoma of Bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Tipifarnib (Primary)
- Indications Bladder cancer
- Focus Therapeutic Use
- 30 Aug 2005 New trial record.